2 Mid-Cap Healthcare Stocks to Buy Now

A recent buyout offer for Aimmune (NASDAQ: AIMT) from its deep-pocketed collaboration partner, Nestle (OTC: NSRGY), drove the biotech stock around 172% higher overnight. As is usually the case following one of these lucrative cash deals, lots of investors have started searching the healthcare sector for mid-sized businesses in the hope they'll deliver similar returns.

These two healthcare gems have moved in opposite directions this year, but both look like great stocks to buy now. Here's why.

Data source: Yahoo! Finance. YTD = year to date.

Continue reading

Source Fool.com